David Urso

David Urso

Chief Executive Officer presso MEI PHARMA, INC.

Patrimonio netto: 9 856 $ in data 31/03/2024

60 anni
Health Technology
Consumer Services
Commercial Services

Profilo

David M.
Urso
was the founder of Tioga Pharmaceuticals, Inc. (founded in 2005) where he held the title of COO, Director & General Counsel from 2013 to 2014.
He is currently the President, Chief Executive Officer & Director at MEI Pharma, Inc. (since 2014).
In his former positions, he worked as the Director-Corporate Development & Legal Affairs at DNA Sciences, Inc. from 2000 to 2002, and as an Attorney at Cooley Godward LLP from 1997 to 2000 and at Wilson Sonsini Goodrich & Rosati PC from 1995 to 1997.
He also worked as a Scientist at GlaxoSmithKline LLC and Perelman School of Medicine.
Mr. Urso received his undergraduate degree from The Reed Institute and his graduate degree from Harvard Law School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
30/10/2023 2 464 ( 0.04% ) 9 856 $ 31/03/2024

Posizioni attive di David Urso

SocietàPosizioneInizio
MEI PHARMA, INC. Chief Executive Officer 02/06/2023
Tutte le posizioni attive di David Urso

Precedenti posizioni note di David Urso

SocietàPosizioneFine
Founder 01/04/2014
General Counsel 01/01/2002
General Counsel 01/01/2000
General Counsel 01/01/1997
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di David Urso

Formazione di David Urso

The Reed Institute Undergraduate Degree
Harvard Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Urso

Relazioni

82

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
MEI PHARMA, INC.

Health Technology

Aziende private5

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Vedi le connessioni aziendali